Prime Medicine (PRME) Current Leases (2021 - 2026)

Prime Medicine (PRME) has 6 years of Current Leases data on file, last reported at $8.5 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 24.61% year-over-year to $8.5 million; the trailing twelve-month figure through Mar 2026 stood at $8.5 million (up 24.61% YoY), and the FY2025 full-year result was $8.1 million, up 125.15% from the prior year.
• Current Leases for Q1 2026 stood at $8.5 million, up from $8.1 million in the prior quarter.
• Across five years, Current Leases topped out at $13.5 million in Q2 2023 and bottomed at $3.6 million in Q4 2024.
• The 5-year median for Current Leases is $8.1 million (2025), against an average of $8.5 million.
• The widest annual swing landed in 2024, when Current Leases sank 61.39%; it then jumped 125.15% in 2025.
• A 5-year view of Current Leases shows it stood at $11.7 million in 2022, then declined by 20.68% to $9.3 million in 2023, then sank by 61.04% to $3.6 million in 2024, then surged by 125.15% to $8.1 million in 2025, then increased by 5.03% to $8.5 million in 2026.
• The last three Current Leases figures came in at $8.5 million (Q1 2026), $8.1 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.

Peer Comparison